Milesi-Hallé Alessandra, Hambuchen Michael D, McMillan Donald E, Michael Owens S
Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, 4301 W. Markham, Little Rock, AR 72205, USA.
Drug Alcohol Depend. 2015 May 1;150:164-9. doi: 10.1016/j.drugalcdep.2015.02.032. Epub 2015 Mar 9.
Because methamphetamine (METH) pharmacokinetics after single iv doses show significant differences between male and female rats, we hypothesized that pharmacokinetic differences in METH disposition could be a contributing factor to the patterns of METH self-administration behaviors in rats.
For the studies, we used a passive (non-contingent) METH dosing schedule consisting of 27 METH iv bolus injections (0.048mg/kg) over 2h derived from a previous active (contingent) METH self-administration behavioral study in male rats. After METH dosing of male and female Sprague-Dawley rats (n=5/group), METH and amphetamine serum concentrations were determined by LC-MS/MS. Pharmacokinetic analysis, including predictive mathematical simulations of the data, was then conducted.
Male and female rats achieved relatively stable METH serum concentrations within 20min, which remained constant from 20 to 120min. While not statistically different, METH clearance and volume of distribution values for females were 25% and 33% lower (respectively) than males. Linear regression analysis of predicted METH concentrations from pharmacokinetic simulations versus observed concentrations showed a substantially better correlation with male data than female data (r(2)=0.71 vs. 0.56; slope=0.95 vs. 0.45, respectively). At 120min, the time of predicted peak METH serum concentrations, female values were 42% higher than expected, while male values were within 3%.
Unlike METH male pharmacokinetic data, the female data was less predictable during multiple METH administrations and produced overall higher than expected METH concentrations. These findings demonstrate that METH pharmacokinetics could contribute to differences in METH self-administration behaviors in rats.
由于单次静脉注射剂量的甲基苯丙胺(METH)在雄性和雌性大鼠中的药代动力学表现出显著差异,我们推测METH处置的药代动力学差异可能是导致大鼠METH自我给药行为模式的一个因素。
在这些研究中,我们采用了一种被动(非条件性)METH给药方案,该方案由27次静脉推注METH(0.048mg/kg)组成,在2小时内完成,此方案源自先前一项针对雄性大鼠的主动(条件性)METH自我给药行为研究。对雄性和雌性斯普拉格-道利大鼠(每组n = 5)进行METH给药后,通过液相色谱-串联质谱法(LC-MS/MS)测定METH和苯丙胺的血清浓度。然后进行药代动力学分析,包括对数据的预测性数学模拟。
雄性和雌性大鼠在20分钟内达到了相对稳定的METH血清浓度,在20至120分钟内保持恒定。虽然无统计学差异,但雌性的METH清除率和分布容积值分别比雄性低25%和33%。药代动力学模拟预测的METH浓度与观察到的浓度的线性回归分析显示,与雄性数据的相关性明显优于雌性数据(r²分别为0.71和0.56;斜率分别为0.95和0.45)。在120分钟时,即预测的METH血清浓度峰值时间,雌性的值比预期高42%,而雄性的值在3%以内。
与雄性METH药代动力学数据不同,雌性数据在多次METH给药期间较难预测,并且产生的METH浓度总体高于预期。这些发现表明,METH药代动力学可能导致大鼠METH自我给药行为的差异。